| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30076117 | HIV | ENSG00000125675.20 | protein_coding | GRIA3 | No | No | 2892 | P42263 Q17R51 Q5XKG2 |
| TVIS30073579 | HIV | ENSG00000125675.20 | protein_coding | GRIA3 | No | No | 2892 | P42263 Q17R51 Q5XKG2 |
| TVIS20006164 | HPV | ENSG00000125675.20 | protein_coding | GRIA3 | No | No | 2892 | P42263 Q17R51 Q5XKG2 |
| TVIS20009131 | HPV | ENSG00000125675.20 | protein_coding | GRIA3 | No | No | 2892 | P42263 Q17R51 Q5XKG2 |
| TVIS20008666 | HPV | ENSG00000125675.20 | protein_coding | GRIA3 | No | No | 2892 | P42263 Q17R51 Q5XKG2 |
| TVIS20040249 | HPV | ENSG00000125675.20 | protein_coding | GRIA3 | No | No | 2892 | P42263 Q17R51 Q5XKG2 |
| TVIS20026966 | HPV | ENSG00000125675.20 | protein_coding | GRIA3 | No | No | 2892 | P42263 Q17R51 Q5XKG2 |
| TVIS20045690 | HPV | ENSG00000125675.20 | protein_coding | GRIA3 | No | No | 2892 | P42263 Q17R51 Q5XKG2 |
| TVIS44029003 | HTLV-1 | ENSG00000125675.20 | protein_coding | GRIA3 | No | No | 2892 | P42263 Q17R51 Q5XKG2 |
| TVIS44043388 | HTLV-1 | ENSG00000125675.20 | protein_coding | GRIA3 | No | No | 2892 | P42263 Q17R51 Q5XKG2 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GRIA3 |
|---|---|
| DrugBank ID | DB14507 |
| Drug Name | Lithium citrate |
| Target ID | BE0000831 |
| UniProt ID | P42263 |
| Regulation Type | |
| PubMed IDs | 10626836 |
| Citations | Karkanias NB, Papke RL: Lithium modulates desensitization of the glutamate receptor subtype gluR3 in Xenopus oocytes. Neurosci Lett. 1999 Dec 31;277(3):153-6. |
| Groups | Approved |
| Direct Classification | Tricarboxylic acids and derivatives |
| SMILES | [Li+].[Li+].[Li+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL1201170 |
